Home
About Us
Locations
Funding
Prevent Breast Cancer
Milestones
Impact
Patient and Public Participation
Contact
Accessibility
Publications
Selected Publications - 2025
Selected Publications - 2024
Selected Publications - 2023
Selected Publications - 2022
Selected Publications - 2021
Selected Publications - 2020
Selected Publications - 2019
Selected Publications - 2018
Selected Publications - 2017
Selected Publications - 2016
Events
Public Outreach Event 2020
IPVC Research Open Day
BreasTalk podcast 2024
TEDx Video 2024
Lobular Breast Cancer Research Partnership Day 2025
Seminars
News
Principal Investigators
Associate PIs
Publications
Selected Publications - 2025
Selected Publications - 2024
Selected Publications - 2023
Selected Publications - 2022
Selected Publications - 2021
Selected Publications - 2020
Selected Publications - 2019
Selected Publications - 2018
Selected Publications - 2017
Selected Publications - 2016
Related Links
The University of Manchester
Christie NHS Foundation Trust
Prevent Breast Cancer
Manchester University NHS Foundation Trust (MFT)
MCRC
Breast Cancer Now
Accessibility
Selected Publications from 2021
Publications
Time-resolved single-cell analysis of Brca1 associated mammary tumorigenesis reveals aberrant differentiation of luminal progenitors
Bach K, Pensa S, Zarocsinceva M, Kania K, Stockis J, Pinaud S, Lazarus KA, Shehata M, Greenhalgh AR, Simões BM, Howell SJ, Clarke RB, Caldas C, Halim TYF, Marioni JC and Khaled WT
Nature Communications
2021
12(1):1502.
Patient and public priorities for breast cancer research: a qualitative study in the UK
Boundouki G, Wilson R, Duxbury P, Henderson J, Balance L, Wray J, Appanah V,3 Ibrahim I, Harvey J, Kirwan CC, on behalf of the Northwest Breast Research
BMJ Open
2021
Jan 29;11(1):e036072
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women
Breast Cancer Association Consortium, Dorling L et al., (Evans DG, Howell A)
N Engl J Med
2021
Jan 20. doi: 10.1056/NEJMoa1913948
Do surgical margins matter after mastectomy?
Bundred J, Michael S, Bowers S, Barnes N, Jauhari Y, Plant D, Maishman T, Cutress R, Holleczek B, Dodwell D, Bundred N
Eur J Surg Oncol
2020
Dec;46(12):2185-2194. doi: 10.1016/j.ejso.2020.08.015. Epub 2020 Aug 2
Residual lymph node tumour burden following removal of a single axillary sentinel lymph node with macrometastatic disease in women with screen detected invasive breast cancer
Dave RV, Cheung S, Sibbering M, Kearins O, Jenkins J, Gandhi A
Br J Surgery Open
2021
5(2) doi.org/10.1093/bjsopen/zraa022
Breast Cancer Management Pathways during the COVID-19 pandemic. Outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study
Dave RV, Kim B, Courtney A, O’Connell R, Rattay T, Taxiarchi VP, Kirkham JJ, Camacho EM, Fairbrother P, Sharma N, Cartlidge C.W.J., Horgan K, McIntosh SA, Leff DR, Vidya R, Potter S, Holcombe C, Copson E, Coles CE, Cutress RI, Gandhi A, Kirwan CC
British Journal of Cancer
2021
May;124(11):1785-1794
Randomised controlled trial of intermittent versus continuous energy restriction during chemotherapy for early breast cancer
Harvie M, Pegington M, Howell SJ, Bundred N, Foden P, Adams J, Graves L, Greystoke A, Mattson MP, Cutler RG, Williamson J, Livingstone K, McMullen D, Sellers K, Lombardelli C, Cooper G, McDiarmid S, Howell A
Br J Cancer
2021
Dec 15. doi: 10.1038/s41416-021-01650-0. Online ahead of print.
Peptide location fingerprinting reveals modification-associated biomarker candidates of ageing in human tissue proteomes
Ozols M, Eckersley A, Mellody KT, Mallikarjun V, Warwood S, O’Cualain R, Knight D, Watson REB, Griffiths CEM, Swift J, Sherratt MJ
Aging Cell
2021
May;20(5):e13355. doi: 10.1111/acel.13355. Epub 2021 Apr 8.
A new framework for developing and evaluating complex interventions: Update of Medical Research Council guidance
Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, Boyd KA, Craig N, French DP, McIntosh E, Petticrew M, Rycroft-Malone J, White M, Moore L
British Medical Journal
2021
374; n2061
Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial
Smith I, Robertson J, Kilburn L, Wilcox M, Evans A, Holcombe C, Horgan K, Kirwan C, Mallon E, Sibbering M, Skene A, Vidya R, Cheang M, Banerji J, Morden J, Sidhu K, Dodson A, Bliss JM, Dowsett M
Lancet Oncol.
2020
Nov;21(11):1443-1454
Elevated EDAR signalling promotes mammary gland tumourigenesis with squamous metaplasia
Williams R, Jobling S, Sims AH, Mou C, Wilkinson L, Collu GM, Streuli CH, Gilmore AP, Headon DJ, Brennan K
Oncogene
2021
Dec 16. doi: 10.1038/s41388-021-01902-6. Online ahead of print. PMID: 34916592
BROWSE: A multicentre comparison of nine year outcomes in acellular dermal matrix based and complete submuscular implant-based immediate breast reconstruction-aesthetics, capsular contracture and patient reported outcomes
Wilson RL, Kirwan CC, O'Donoghue JM, Linforth RA, Johnson RK, Harvey JR
Eur J Surg Oncol.
2021
Nov 6:S0748-7983(21)00776-9. doi: 10.1016/j.ejso.2021.10.026. Epub ahead of print. PMID: 34836730.
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
Woo et al., PDXNET consortium & EurOPDX consortium (Clarke RB)
Nature Genetics
2021
53(1):86-99
Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer
Woodward ER, van Veen EM, Forde C, Harkness EF, Byers HJ, Ellingford JM, Burghel GJ, Schlech H, Bowers NL, Wallace AJ, Howell SJ, Howell A, Lalloo F, Newman WG, Smith MJ, Gareth Evans D
Genet Med
2021
Jun 10. doi: 10.1038/s41436-021-01234-6
The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion
Xu Q, Zhang J, Telfer B, Zhang H, Ali N, Chen F, Risa B, Pearson AJ, Zhang W, Finegan KG, Ucar A, Giurisato E, Tournier C
Oncogene
2021
40, 3929-3941.
Seminars